Literature DB >> 10422821

The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model.

T Yasui1, K Fujita, M Sato, M Sugimoto, M Iguchi, S Nomura, K Kohri.   

Abstract

Kampo medicine is a traditional Japanese therapeutic system which originated in China and was used to treat various diseases for hundreds of years. Kampo medicine had been also used for the cure and the prevention of urinary calculi for many years, but the effect and the mechanism of this use of kampo medicine are unclear. We examined the inhibitory effect of the kampo medicine takusha on the formation of calcium oxalate renal stones induced by ethylene glycol (EG) and vitamin D3 in rats. We also investigated the effect of takusha on osteopontin (OPN) expression, which we previously identified as an important stone matrix protein. The control group rats were non-treated; the stone group rats were administered EG and vitamin D3, and the takusha group was administered takusha in addition to EG and vitamin D3. The rate of renal stone formation was lower in the takusha group than in the stone group; thus, the OPN expression in the takusha group was smaller than in the stone group. Takusha was effective in preventing oxalate calculi formation and OPN expression in rats. These findings suggest that takusha prevents stone formation including not only calcium oxalate aggregation but also proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10422821     DOI: 10.1007/s002400050109

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  12 in total

1.  Chinese herbal medicines and their efficacy in treating renal stones.

Authors:  Mayur Danny I Gohel; Siu Ping Wong
Journal:  Urol Res       Date:  2006-12

2.  Antiurolithic effects of medicinal plants: results of in vivo studies in rat models of calcium oxalate nephrolithiasis-a systematic review.

Authors:  Aslam Khan; Samra Bashir; Saeed R Khan
Journal:  Urolithiasis       Date:  2021-01-23       Impact factor: 3.436

3.  Protective effect of Flos carthami extract against ethylene glycol-induced urolithiasis in rats.

Authors:  Wu-Chou Lin; Ming-Tsung Lai; Huey-Yi Chen; Chien-Yi Ho; Kee-Ming Man; Jui-Lung Shen; Yuan-Ju Lee; Fuu-Jen Tsai; Yung-Hsiang Chen; Wen-Chi Chen
Journal:  Urol Res       Date:  2012-03-08

4.  Effect of indigenous plant extracts on calcium oxalate crystallization having a role in urolithiasis.

Authors:  Fauzia Yasir; Muhammad A Waqar
Journal:  Urol Res       Date:  2011-06-04

5.  Effect of Cystone® on urinary composition and stone formation over a one year period.

Authors:  S B Erickson; T J Vrtiska; J C Lieske
Journal:  Phytomedicine       Date:  2011-03-17       Impact factor: 5.340

6.  Wu-Ling-San formula prophylaxis against recurrent calcium oxalate nephrolithiasis - a prospective randomized controlled trial.

Authors:  Eugene Lin; Lin Ho; Mao-Sheng Lin; Min-Ho Huang; Wen-Chi Chen
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-08-12

7.  Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers.

Authors:  Stephen B Erickson; Terri J Vrtiska; Vincent J Canzanello; John C Lieske
Journal:  Urol Res       Date:  2010-12-16

Review 8.  Herbal medicines in the management of urolithiasis: alternative or complementary?

Authors:  Veronika Butterweck; Saeed R Khan
Journal:  Planta Med       Date:  2009-05-14       Impact factor: 3.352

9.  Antiurolithiatic and antioxidant activity of Mimusops elengi on ethylene glycol-induced urolithiasis in rats.

Authors:  Purnima Ashok; Basavaraj C Koti; A H M Vishwanathswamy
Journal:  Indian J Pharmacol       Date:  2010-12       Impact factor: 1.200

10.  A traditional Chinese herbal antilithic formula, Wulingsan, effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats.

Authors:  Chou-Huang Tsai; Yu-Cheng Chen; Lieh-Der Chen; Tien-Chien Pan; Chien-Yi Ho; Ming-Tsung Lai; Fuu-Jen Tsai; Wen-Chi Chen
Journal:  Urol Res       Date:  2007-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.